<DOC>
	<DOC>NCT01767324</DOC>
	<brief_summary>The goal of this exploratory study is to select the optimal body site for intracutaneous delivery of 0.5 milliliters of saline from the FLUGEN 101.2 microneedle-based device.</brief_summary>
	<brief_title>Site Selection for Intracutaneous Saline Delivery</brief_title>
	<detailed_description />
	<criteria>Able to read and/or understand and sign the Informed Consent Form Medical history of acute or chronic skin disease Active skin allergy or acute skin infection, tattoo(s), scars, sunburn or skin abnormalities at any prospective injection site Hirsute at any prospective injection site Diabetes High levels of anxiety or depression or history of psychosis Abuse of alcohol or use of other drugs of abuse including tobacco Pregnant or breastfeeding women Any medical condition that may interfere with study protocol adherence including completion of study activities Foreseeable inability to complete the study as scheduled.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>microneedle-based array</keyword>
	<keyword>hollow microneedle</keyword>
	<keyword>intracutaneous</keyword>
	<keyword>drug delivery</keyword>
	<keyword>vaccine delivery</keyword>
</DOC>